We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAAS
901
DELISTED
DigiAsia
FAAS
$9.5M 0.02%
954,451
XPOA
902
DELISTED
DPCM Capital, Inc.
XPOA
$9.49M 0.02%
959,930
CPE
903
DELISTED
Callon Petroleum Company
CPE
$9.49M 0.02%
+160,666
New +$8.79M
TRIS
904
DELISTED
Tristar Acquisition I Corp.
TRIS
$9.49M 0.02%
962,522
IMAQ
905
DELISTED
International Media Acquisition Corp. Class A Common Stock
IMAQ
$9.49M 0.02%
957,466
WULF icon
906
TeraWulf
WULF
$8.77B
$9.47M 0.02%
1,127,612
+335,223
+42% +$3.67M
AIG icon
907
American International
AIG
$42.1B
$9.47M 0.02%
150,917
-168,638
-53% -$10.1M
IRDM icon
908
Iridium Communications
IRDM
$4.84B
$9.43M 0.02%
234,018
+232,086
+12,013% +$8.74M
DVAX
909
DELISTED
Dynavax Technologies
DVAX
$9.39M 0.02%
866,332
+14,437
+2% +$175K
AERT
910
Aeries Technology
AERT
$35.9M
$9.38M 0.02%
118,974
LNG icon
911
Cheniere Energy
LNG
$54.5B
$9.35M 0.02%
+67,427
New +$8.19M
SNTI icon
912
Senti Biosciences Holdings
SNTI
$11.5M
$9.34M 0.02%
94,547
+45,188
+92% +$4.46M
WFRD icon
913
Weatherford International
WFRD
$6.22B
$9.33M 0.02%
279,992
-15,801
-5% -$495K
RXDX
914
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$9.32M 0.02%
+246,855
New +$9.76M
IIII
915
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
$9.3M 0.02%
946,933
PSA icon
916
Public Storage
PSA
$60.4B
$9.3M 0.02%
23,821
+12,431
+109% +$4.51M
HLT icon
917
Hilton Worldwide
HLT
$74.7B
$9.28M 0.02%
61,161
-243,258
-80% -$35.9M
BNZI icon
918
Banzai International
BNZI
$7.09M
$9.21M 0.02%
94
LOCC
919
DELISTED
Live Oak Crestview Climate Acquisition Corp.
LOCC
$9.21M 0.02%
949,986
MTSI icon
920
MACOM Technology Solutions
MTSI
$19.7B
$9.21M 0.02%
+153,883
New +$9.62M
OSTR
921
DELISTED
Oyster Enterprises Acquisition Corp. Class A Common Stock
OSTR
$9.21M 0.02%
941,011
+224,713
+31% +$2.19M
JOYY
922
JOYY Inc
JOYY
$3.78B
$9.19M 0.02%
250,234
+220,945
+754% +$9.98M
CIIG
923
DELISTED
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
$9.16M 0.02%
927,652
SRRA
924
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$9.13M 0.02%
+284,781
New +$8.17M
RCL icon
925
Royal Caribbean
RCL
$77.8B
$9.12M 0.02%
108,901
-432,490
-80% -$34.1M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.